Latest stories on ADCT
ADC Therapeutics SA (ADCT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
Seeking Alpha55 · neutralgeneral
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
PR Newswire55 · neutralgeneral
ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses
Yahoo Top34 · bearishearnings
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
The Motley Fool34 · bearishearnings
ADC Therapeutics price target lowered to $5 from $10 at Guggenheim
The Fly32 · bearishanalyst
ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year
The Fly56 · neutralearnings
ADC Therapeutics signals cash runway into 2028 while assessing LOTIS-5 regulatory path forward
Seeking Alpha58 · neutralgeneral
ADC Therapeutics SA (ADCT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
ADC Therapeutics Reports Q2 2026 Results, Reassesses ZYNLONTA Path
TipRanks48 · neutralearnings
ADC Therapeutics SA (ADCT) files 8-K
SEC 8-K50 · neutralgeneral
ADC Therapeutics Non-GAAP EPS of -$0.11, revenue of $19.25M beats by $0.35M
Seeking Alpha56 · neutralearnings
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
PR Newswire55 · neutralearnings
ADC Therapeutics Q2 Earnings Preview
Seeking Alpha48 · neutralearnings
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
PR Newswire50 · neutralearnings
ADC Therapeutics Grants One-Time Retention Awards to Executives
TipRanks50 · neutralgeneral
ADC Therapeutics SA (ADCT) files 8-K
SEC 8-K50 · neutralgeneral
ADC Therapeutics Announces New Employee Inducement Grant
PR Newswire50 · neutralgeneral
ADC Therapeutics Announces New Employee Inducement Grant | ADCT Stock News
StockTitan50 · neutralgeneral
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
PR Newswire63 · neutralproduct/pr
ADC Therapeutics Announces ZYNLONTA-Focused Strategic Reorganization
TipRanks55 · neutralgeneral
ADC Therapeutics To Cut About 17% Of Its Staff – A Look At Some Key Details
Stocktwits News38 · neutralgeneral
ADC Therapeutics SA (ADCT) files 8-K
SEC 8-K50 · neutralgeneral
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
PR Newswire38 · neutralgeneral
ADC Therapeutics SA (ADCT) Discusses Phase III LOTIS-5 Trial Results and Next Steps in DLBCL - Slideshow
Seeking Alpha50 · neutralgeneral
ADC Therapeutics: 'Sell' LOTIS-5 Underwhelms And Possible Change In Strategy
Seeking Alpha32 · bearishanalyst